GB1042379A - Improvements in or relating to polyuronides - Google Patents

Improvements in or relating to polyuronides

Info

Publication number
GB1042379A
GB1042379A GB33679/63A GB3367963A GB1042379A GB 1042379 A GB1042379 A GB 1042379A GB 33679/63 A GB33679/63 A GB 33679/63A GB 3367963 A GB3367963 A GB 3367963A GB 1042379 A GB1042379 A GB 1042379A
Authority
GB
United Kingdom
Prior art keywords
polyuronide
ether
plant juice
compositions
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB33679/63A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to NL297511D priority Critical patent/NL297511A/xx
Priority to US629460A priority patent/US3103466A/en
Application filed by Individual filed Critical Individual
Priority to GB33679/63A priority patent/GB1042379A/en
Publication of GB1042379A publication Critical patent/GB1042379A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
GB33679/63A 1956-12-20 1963-08-26 Improvements in or relating to polyuronides Expired GB1042379A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
NL297511D NL297511A (US07902200-20110308-C00004.png) 1956-12-20
US629460A US3103466A (en) 1956-12-20 1956-12-20 Topical medicament including polyuronide derived from aloe
GB33679/63A GB1042379A (en) 1956-12-20 1963-08-26 Improvements in or relating to polyuronides

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US629460A US3103466A (en) 1956-12-20 1956-12-20 Topical medicament including polyuronide derived from aloe
GB33679/63A GB1042379A (en) 1956-12-20 1963-08-26 Improvements in or relating to polyuronides

Publications (1)

Publication Number Publication Date
GB1042379A true GB1042379A (en) 1966-09-14

Family

ID=26261970

Family Applications (1)

Application Number Title Priority Date Filing Date
GB33679/63A Expired GB1042379A (en) 1956-12-20 1963-08-26 Improvements in or relating to polyuronides

Country Status (3)

Country Link
US (1) US3103466A (US07902200-20110308-C00004.png)
GB (1) GB1042379A (US07902200-20110308-C00004.png)
NL (1) NL297511A (US07902200-20110308-C00004.png)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000041541A2 (en) * 1999-01-12 2000-07-20 Vito-Mannan Polysaccharide L.L.C. Method of isolating mucilaginous polysaccharides and uses thereof
WO2007039754A1 (en) 2005-10-06 2007-04-12 Ntnu Technology Transfer As Use of oligouronates for treating mucus hyperviscosity
US8529890B2 (en) 2009-03-23 2013-09-10 Ntnu Technology Transfer As Composition for the administration of polymeric drugs
US8680072B2 (en) 2007-11-27 2014-03-25 Algipharma As Use of alginate oligomers in combating biofilms
US8815831B2 (en) 2009-06-03 2014-08-26 Algipharma As Treatment of Acinetobacter with alginate oligomers and antibiotics
US8841279B2 (en) 2007-04-12 2014-09-23 Norwegian University Of Science And Technology Oligo-guluronate and galacturonate compositions
US8987215B2 (en) 2009-03-23 2015-03-24 Ntnu Technology Transfer As Composition for use in gene therapy

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3479432A (en) * 1963-02-14 1969-11-18 Purdue Frederick Co N-methylglucammonium polygalacturonate demulcent compositions and methods of treatment therewith
US3352753A (en) * 1965-03-19 1967-11-14 Squibb & Sons Inc Pharmaceutical compositions of corticosteroids in gelled alcohol
US3470109A (en) * 1968-01-31 1969-09-30 Aloe Creme Lab Inc Method of making reconstitutable aloe gel in crystalline form
US3878197A (en) * 1972-12-13 1975-04-15 Ray H Maret Process for preparing extracts of aloe vera
US4585650A (en) * 1982-10-04 1986-04-29 White Laboratories, Inc. Skin lubricating cosmetic composition
US4861761A (en) * 1984-06-28 1989-08-29 Dr. Madis Laboratories, Inc. Aloeferon isolation, manufacturing and its applications
US5234914A (en) * 1991-06-11 1993-08-10 Patent Biopharmaceutics, Inc. Methods of treating hemorrhoids and anorecial disease
US5565189A (en) * 1995-02-03 1996-10-15 Mulder; Gerit D. Wound cleanser method of use
US5824659A (en) * 1996-09-04 1998-10-20 Board Of Regents, The University Of Texas System Cytoprotective oligosaccharide from Aloe preventing damage to the skin immune system by UV radiation
EP1323738A1 (en) * 2001-12-27 2003-07-02 2QR Research BV Negatively charged polysaccharide derivable form Aloe Vera
CN101720226B (zh) 2007-05-11 2013-01-30 芦荟研究实验室公司 用于皮肤增强的芦荟制剂
US7833829B2 (en) * 2008-10-28 2010-11-16 Honeywell International Inc. MEMS devices and methods of assembling micro electromechanical systems (MEMS)
WO2014175814A1 (en) * 2013-04-26 2014-10-30 Bioglan Ab Composition for use in reducing scab formation and promoting healing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1167230A (en) * 1909-07-29 1916-01-04 Knoll And Company Medicinal extract of aperient drugs.
US2376656A (en) * 1942-05-20 1945-05-22 American Maize Prod Co Dispersion of gums

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000041541A2 (en) * 1999-01-12 2000-07-20 Vito-Mannan Polysaccharide L.L.C. Method of isolating mucilaginous polysaccharides and uses thereof
WO2000041541A3 (en) * 1999-01-12 2001-11-15 Vito Mannan Polysaccharide L L Method of isolating mucilaginous polysaccharides and uses thereof
US6482942B1 (en) 1999-01-12 2002-11-19 Biotechnology Services And Consulting, Inc. Method of isolating mucilaginous polysaccharides and uses thereof
AU2006298544B2 (en) * 2005-10-06 2012-07-05 Ntnu Technology Transfer As Use of oligouronates for treating mucus hyperviscosity
US8673878B2 (en) 2005-10-06 2014-03-18 Ntnu Technology Transfer As Mucosal treatment
WO2007039760A3 (en) * 2005-10-06 2007-08-09 Ntnu Technology Transfer As Use of oligouronates for treating mucus hyperviscosity
CN101325973A (zh) * 2005-10-06 2008-12-17 Ntnu技术转让公司 寡聚糖醛酸盐用于治疗粘液高粘度的用途
EP2311497A1 (en) * 2005-10-06 2011-04-20 NTNU Technology Transfer AS Use of oligouronates
EA015436B1 (ru) * 2005-10-06 2011-08-30 ЭнТиЭнЮ ТЕКНОЛОДЖИ ТРАНСФЕР АС Применение олигоуронатов для лечения повышенной вязкости слизи
KR101144576B1 (ko) 2005-10-06 2012-05-09 엔티엔유 테크놀로지 트랜스퍼 에이에스 점액 고점도를 치료하기 위한 올리고우로네이트의 용도
WO2007039754A1 (en) 2005-10-06 2007-04-12 Ntnu Technology Transfer As Use of oligouronates for treating mucus hyperviscosity
US8754063B2 (en) 2005-10-06 2014-06-17 NTNU Technology Transfers AS Use of oligouronates for treating mucus hyperviscosity
WO2007039760A2 (en) * 2005-10-06 2007-04-12 Ntnu Technology Transfer As Use of oligouronates for treating mucus hyperviscosity
US8841279B2 (en) 2007-04-12 2014-09-23 Norwegian University Of Science And Technology Oligo-guluronate and galacturonate compositions
US8680072B2 (en) 2007-11-27 2014-03-25 Algipharma As Use of alginate oligomers in combating biofilms
US9877983B2 (en) 2007-11-27 2018-01-30 Algipharma As Use of alginate oligomers in combating biofilms
US10624920B2 (en) 2007-11-27 2020-04-21 Algipharma As Use of alginate oligomers in combating biofilms
US8529890B2 (en) 2009-03-23 2013-09-10 Ntnu Technology Transfer As Composition for the administration of polymeric drugs
US8987215B2 (en) 2009-03-23 2015-03-24 Ntnu Technology Transfer As Composition for use in gene therapy
US8815831B2 (en) 2009-06-03 2014-08-26 Algipharma As Treatment of Acinetobacter with alginate oligomers and antibiotics
US9018158B2 (en) 2009-06-03 2015-04-28 Algipharma As Alginate oligomers for use in overcoming multidrug resistance in bacteria
US9801901B2 (en) 2009-06-03 2017-10-31 Algipharma As Alginate oligomers for use in overcoming multidrug resistance in bacteria

Also Published As

Publication number Publication date
US3103466A (en) 1963-09-10
NL297511A (US07902200-20110308-C00004.png)

Similar Documents

Publication Publication Date Title
GB1042379A (en) Improvements in or relating to polyuronides
Alexander et al. The excretion of ethylquinone by the flour beetle
GB1457632A (en) Adriamycins
GB791704A (en) Detergent compositions
ES431601A1 (es) Un procedimiento para preparar una formulacion que contiene prostaglandina del grupo e estable.
US2113374A (en) Salicylic acid derivatives
ES8106835A1 (es) Procedimiento para la preparacion de una composicion acuosa neutralizadora del acido gastrico.
GB1388330A (en) Method of preparing stable aqueous solutions of organosilicic compounds and the resulting products and applications thereof
US4132782A (en) Method for suppressing herpes simplex virus
GB1068534A (en) Polysaccharide having anti-cancer activity
GB444276A (en) An improved process for the manufacture of medicinal preparations containing chlorophyll or chlorophylline
GB858783A (en) Improvements in or relating to vitamin b compositions
Schroeder et al. Cytotoxic Activity of 6, 20–Epoxylathyrol and its Aliphatic Diesters
JPS5538338A (en) Clathrate compound and its preparation
FR2424928A1 (fr) 1,6-dimesyl-3,4-dimethyl-d-mannitol, procede pour sa preparation et medicaments le contenant
JPS5684720A (en) Deodorization of polyoxyalkylene compound
GB515386A (en) Process for preparing germicides and products thereof
GB643056A (en) Improvements in or relating to therapeutic substances
GB782469A (en) Anti-t.b. factor
Kispersky et al. Nitration in the Presence of Polyphosphoric Acid
JPS54134712A (en) Shampoo composition
JPS5455735A (en) Agent for enhancing antithrombin activity
ES365965A1 (es) Procedimiento de preparacion de una composicion antisebo- rreica destinada a ser aplicada al cuero cabelludo.
JPS5718969A (en) Preparation of organic complex from essential nutrient metallic element
GB981341A (en) Pharmaceutical compositions for improving circulatory troubles in lower or upper members